Entropy Neurodynamics

Entropy Neurodynamics PP&E per Employee

PP&E per Employee of Entropy Neurodynamics (ENP.AX) as of Oct 18, 2026.

PP&E per Employee

-AUD

Last updated:

PP&E per Employee of Entropy Neurodynamics is 2026 - AUD. PP&E per Employee of Entropy Neurodynamics was 2025 - AUD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Entropy Neurodynamics Stock analysis

What does Entropy Neurodynamics do? Entropy Neurodynamics Ltd, based in Melbourne, Australia, operates in the Health Care sector within Biotechnology. The company develops and commercializes exosomes as therapeutic agents, focusing on exosome technology and holding a portfolio of intellectual property related to exosome manufacturing. It offers proprietary technologies such as LEAP manufacturing, LOAD API loading, and EVPS tropism to pharmaceutical and biotechnology firms seeking to leverage exosome delivery systems for their products. Listed on 18 December 2018, the company invests in biopharmaceutical drug development. Entropy Neurodynamics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Entropy Neurodynamics stock

On Eulerpool you can find the complete historical development of PP&E per Employee Entropy Neurodynamics since 2006 – with annual values, charts, and detailed analysis.

PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.

PP&E per Employee's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's Entropy Neurodynamics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Entropy Neurodynamics

All Key Metrics — Entropy Neurodynamics